An Open-Label, Long-Term Safety Study of A Long-acting Human Growth Hormone Somavaratan (VRS-317) in Children with Growth Hormone Deficiency The VISTA Study: Versartis Long-Term Safety Study of Somavaratan Save

Date Added
February 28th, 2017
PRO Number
Pro00060869
Researcher
Deborah Bowlby
Keywords
Pediatrics
Summary

This study is designed as a long-term safety study and is a multi-center, parallel dose, open-label study assessing long-term somavaratan administration. It is open to subjects completing a somavaratan clinical study in children with GHD, as well as up to 200 new treatment na

Institution
MUSC
Recruitment Contact
Amanda Blue
843-792-1005
blueae@musc.edu

NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES Save

Date Added
June 5th, 2012
PRO Number
Pro00016672
Researcher
Deborah Bowlby
Keywords
Diabetes, Insulin, Pediatrics
Summary

This study is providing annual blood tests looking at diabetes autoantibodies for first degree relatives of patients diagnosed with type 1 diabetes who are between the ages of 1 and 45. It will also provide "diabetes screening" for second and third degree relatives age 1-20. Often parents and/or relatives wonder "if they will get diabetes" down the road or if additional offspring are "at risk" for type 1 diabetes. This study aims at assisting families with free blood testing. If positive, participants will be eligible for "prevention studies". MUSC is currently only participating in the "screening or Natural History" portion of TrialNet.

Institution
MUSC
Recruitment Contact
Amanda Blue
843-792-1005
blueae@musc.edu

Change_preferences

-- OR --

Create_login